EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

NR0B1 augments sorafenib resistance in hepatocellular carcinoma through promoting autophagy and inhibiting apoptosis

Xiao Lan Tan, Zhaokun Wang, Shunyao Liao, Ming Yi, Dachang Tao, Xinyue Zhang, Xiangyou Leng, Jiaying Shi, Shengyu Xie, Yuan Yang, Yun Qiang Liu iD

Cancer Science · 2024-02 · 115 (2) · 465-476

DOI: 10.1111/cas.16029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 22.11.2023. Verfasst von Xiao Lan Tan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NR0B1 is frequently activated in hepatocellular carcinoma (HCC). However, the role of NR0B1 is controversial in HCC. In this study, we observed that NR0B1 was an independent poor prognostic factor, negatively correlated with the overall survival of HCC and the relapse‐free survival of patients treated with sorafenib. Meanwhile, NR0B1 promoted the proliferation, migration, and invasion of HCC cells, inhibited sorafenib‐induced apoptosis, and elevated the IC50 of sorafenib in HCC cells. NR0B1 was further displayed to increase sorafenib‐induced autophagic vesicles and activate Beclin1/LC3‐II‐dependent autophagy pathway. Finally, NR0B1 was revealed to transcriptionally suppress GSK3β that restrains AMPK/mTOR‐driven autophagy and increases BAX‐mediated apoptosis. Collectively, our study uncovered that the ectopic expression of NR0B1 augmented sorafenib‐resistance in HCC cells by activating autophagy and inhibiting apoptosis. Our findings supported that NR0B1 was a detrimental factor for HCC prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansSorafenibDrug Resistance, NeoplasmNeoplasm Recurrence, LocalApoptosisAutophagyCell ProliferationCell Line, TumorDAX-1 Orphan Nuclear Receptor

Stichwörter der Autor:innen

NR0B1apoptosisautophagyhepatocellular carcinoma (HCC)sorafenib resistance

Substanzen

SorafenibNR0B1 protein, humanDAX-1 Orphan Nuclear Receptor

Autor:innen und Institutionen

  • Department of Medical Genetics and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Institute of Gerontology and Center for Geriatrics, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.

ORCID-Profile: Yun Qiang Liu

Förderung

  • National Natural Science Foundation of China
  • Sichuan Science and Technology Program

Zitieren

APA

Tan, X. L., Wang, Z., Liao, S., Yi, M., Tao, D., Zhang, X., Leng, X., Shi, J., Xie, S., Yang, Y., & Liu, Y. Q. (2024). NR0B1 augments sorafenib resistance in hepatocellular carcinoma through promoting autophagy and inhibiting apoptosis. Cancer Science, 115(2), 465-476. https://doi.org/10.1111/cas.16029

Vancouver

Tan XL, Wang Z, Liao S, Yi M, Tao D, Zhang X, et al. NR0B1 augments sorafenib resistance in hepatocellular carcinoma through promoting autophagy and inhibiting apoptosis. Cancer Science. 2024;115(2):465-476. doi:10.1111/cas.16029

BibTeX
@article{Tan2024,
  author = {Tan, Xiao Lan and Wang, Zhaokun and Liao, Shunyao and Yi, Ming and Tao, Dachang and Zhang, Xinyue and Leng, Xiangyou and Shi, Jiaying and Xie, Shengyu and Yang, Yuan and Liu, Yun Qiang},
  title = {NR0B1 augments sorafenib resistance in hepatocellular carcinoma through promoting autophagy and inhibiting apoptosis},
  journal = {Cancer Science},
  year = {2024},
  volume = {115},
  number = {2},
  pages = {465--476},
  doi = {10.1111/cas.16029}
}
Kostenlos starten →